A client is receiving miotics for the treatment of open-angle glaucoma. The nurse determines that a priority nursing problem is the risk for injury. This nursing problem is based on which etiology?

Choice A reason:

Decreased night vision is a significant concern for clients receiving miotics for open-angle glaucoma. Miotics, such as pilocarpine, work by constricting the pupil (miosis), which can reduce the amount of light entering the eye. This effect is particularly problematic in low-light conditions, leading to decreased night vision and increasing the risk of injury due to poor visibility

Choice B reason:

Increased sensitivity to light, also known as photophobia, can occur with the use of miotics, but it is not the primary concern related to the risk of injury. While photophobia can cause discomfort and avoidance of bright environments, it does not directly contribute to the risk of injury as significantly as decreased night vision.

Choice C reason:

Increased frequency of lacrimation (tearing) can be a side effect of miotics, but it is not a major factor in the risk of injury. Excessive tearing can cause discomfort and blurred vision temporarily, but it does not pose a significant risk for injury compared to decreased night vision.

Choice D reason:

Diminished color perception is not a common side effect of miotics. Miotics primarily affect the pupil size and accommodation, rather than color vision. Therefore, this choice is not relevant to the risk of injury associated with the use of miotics.

Choice A Reason:

I should take this medication only when I am having an asthma attack: This statement is incorrect because montelukast is not a rescue medication. It is a maintenance medication designed to be taken regularly to prevent asthma symptoms and attacks. Using it only during an asthma attack would not provide the intended preventive benefits.

Choice B Reason:

I will not need to use my inhalers twice a day when I start this medicine: This statement is also incorrect. Montelukast is often used as an adjunct therapy and does not replace the need for inhalers, especially for those with moderate to severe asthma. Inhalers, particularly corticosteroids, remain a critical part of asthma management.

Choice C Reason:

I will take the tablet every evening to control my asthma: This statement is correct. Montelukast is typically prescribed to be taken once daily in the evening. This helps to control asthma symptoms and prevent attacks by reducing inflammation and constriction in the airways.

Choice D Reason:

This medication will stop an asthma attack immediately: This statement is incorrect. Montelukast is not a fast-acting medication and will not provide immediate relief during an asthma attack. Fast-acting bronchodilators, such as albuterol, are used for immediate relief.